2D9-25083-26608
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 850 / AZ
- Registered
- 2021-08-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-17
Dose 1 — Pfizer-BioNTech
-
2021-08-18
Registered in v-safe
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-23
- 2021-08-24
- 2021-08-31
- 2021-09-07
- 2021-09-14
- 2021-09-21
-
2021-09-22
Dose 2 — Pfizer-BioNTech
- 2021-09-28
- 2021-09-29
- 2021-10-06
- 2021-10-15
- 2021-10-20
-
2021-10-27
Survey response — day 35, dose 2MedDRA: Anxiety — Feeling: Good · Be unable to do your normal daily activitiesFree text: Higher anxietyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Survey response — day 42, dose 2MedDRA: Anxiety, Obsessive-compulsive disorder — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Anxiety/OCDMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-17 | Pfizer-BioNTech | No |
| 2 | 2021-09-22 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 2
Symptoms: Higher anxiety
Release 10 — day 42, dose 2
Symptoms: Anxiety/OCD
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | Obsessive-compulsive disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release